Planet Biopharmaceuticals, Inc. — Form D
Planet Biopharmaceuticals, Inc. of DANBURY, CT, a company, filed a Form D exempt-offering notice with the SEC on 2010-09-17. The offering totals $1.7M, of which $1.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2010-09-17
- Form: D
- Accession: 0001501507-10-000002
- Industry: Other Health Care
- Exemptions: 05, 06, 46
- Total offering: $1.7M
- Amount sold: $1.5M
- Remaining: $157K
- Minimum investment: $30K
- Investors: 3
- Date of first sale: 2010-08-31
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-147909
Issuer
- Name: Planet Biopharmaceuticals, Inc.
- CIK: 0001501507
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 22 SHELTER ROCK LANE, UNIT 51, DANBURY, CT, 06810
- Phone: 816-792-8512
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Robert Cole | Director | New York, NY |
| Francesca DiNota | Director | Danbury, CT |
| Scott Glenn | Director | San Diego, CA |
| WILLIAM GOLDBERG | Director | POMPANO BEACH, FL |
| Andrew Schiff | Director | New York, NY |
| BRETT ZBAR | Director | WINSTON-SALEM, NC |
| Francesca DiNota | Executive Officer | Danbury, CT |
| WILLIAM GOLDBERG | Executive Officer | POMPANO BEACH, FL |
More